Position in PYXS
as of Dec 31, 2025
· filed Jan 29, 2026
Position Value
$2,686,132
-$2,117,861 QoQ
Shares Held
2,335,768
+7.9% QoQ
Ownership
3.69%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 12.882144117052722.ToString("F0")%
None 87.11785588294728.ToString("F0")%
Common Shares in PYXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025VANGUARD GROUP INC holds $65,710,461,655 across 449 Biotechnology names. PYXS ranks #303 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,105,823 | $10,928,615,912 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,075,153 | $7,004,838,343 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,553,932 | $5,389,721,058 | |
| 4 | INSM |
INSMED Inc
|
21,076,344 | $3,668,126,907 | |
| 5 | INCY |
Incyte Corp
|
19,911,434 | $1,966,652,333 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
16,719,886 | $1,331,738,919 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
16,440,459 | $1,300,604,709 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
16,862,691 | $1,289,827,232 |
All Filings in PYXS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $2,686,132 | 2,335,768 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $4,803,993 | 2,163,962 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $2,364,334 | 2,149,396 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,387,991 | 2,436,728 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $3,808,198 | 2,441,153 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $8,928,936 | 2,432,953 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,820,068 | 2,060,444 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,970,070 | 1,401,425 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,352,032 | 1,306,685 | Shares | Defined | 2024-03-11 | |
| 2023-09-30 | $2,269,082 | 1,140,243 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $2,806,908 | 1,096,449 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,260,821 | 1,062,549 | Shares | Sole | 2023-07-14 | |
| 2022-12-31 | $1,229,887 | 917,827 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,807,246 | 917,384 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,020,810 | 849,080 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,126,287 | 526,309 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,707,668 | 520,298 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||